Greenway Medical Technologies Announces Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Initial Public Offering

CARROLLTON, Ga., Feb. 7, 2012 /PRNewswire/ -- Greenway Medical Technologies, Inc. ("Greenway®") (NYSE: GWAY), provider of the integrated, single-database electronic health record (EHR), practice management and interoperability solution PrimeSUITE® 2011, today announced that the underwriters of Greenway's recent initial public offering of its common stock exercised in full their option to purchase an additional 1,000,000 shares of common stock at $10.00 per share, less underwriting discounts and commissions. The option was granted in connection with Greenway's initial public offering of 6,666,667 shares. As a result, the total initial public offering size is 7,666,667 shares, which consists of 6,388,833 shares sold by Greenway and 1,277,834 shares sold by the selling stockholders. Including proceeds from the exercise of the option, net proceeds to Greenway from the initial public offering are approximately $57.2 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by Greenway. Greenway did not receive any proceeds from the sale of shares by the selling stockholders. The closing of the sale of all 7,666,667 shares of Greenway's common stock to the underwriters occurred earlier today.

J.P. Morgan and Morgan Stanley acted as active book-runners and William Blair acted as passive book-runner. The offering is being made solely by means of a prospectus forming part of the effective registration statement. A copy of the final prospectus relating to this offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by calling toll-free at 1-866-803-9204; from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 (Tel: 1-866-718-1649), Email: [email protected]; from William Blair & Company, Attn: Prospectus Department, 222 West Adams Street, Chicago, IL 60606: 1-800-621-0687.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on February 1, 2012. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Greenway Medical Technologies, Inc.

Greenway Medical Technologies provides innovative EHR, ambulatory healthcare and clinical research business solutions and services to more than 33,000 healthcare providers nationwide, in 30 specialties and subspecialties, by enhancing the delivery of patient care through advanced health IT software and on-demand services that allow physician practices to function at their highest level of efficiency in group practice, IDN, REC, HIE, IPA, Accountable Care Organization (ACO) and Patient-Centered Medical Home (PCMH) settings. Established in 1998, Carrollton, Ga.-based Greenway has more than 500 employees.

SOURCE Greenway Medical Technologies, Inc.